These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 6357202)

  • 1. [Pharmacodynamics and pharmacokinetics of memantine].
    Wesemann W; Sontag KH; Maj J
    Arzneimittelforschung; 1983; 33(8):1122-34. PubMed ID: 6357202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effect of memantine on central neurotransmitter systems. Review of the results].
    Maj J
    Arzneimittelforschung; 1982; 32(10):1256-9. PubMed ID: 6129854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [The Effect of memantine on spinal alpha-motoneurons and on the content of dopamine, noradrenaline and serotonin in the striatum and lumbar spinal cord].
    Sontag KH; Wand P; Schwarz M; Wesemann W; Osborne NN
    Arzneimittelforschung; 1982; 32(10):1236-40. PubMed ID: 6891222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [The effect of memantine (dimethylamino-adamantane) on membranes of sensory nerve fibres (author's transl)].
    Grossmann W; Jurna I
    Arzneimittelforschung; 1977 Jul; 27(7):1483-7. PubMed ID: 578479
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potentiation of the locomotor activity of memantine by aminophylline.
    Youssif N; Ammon HP
    Arzneimittelforschung; 1986 Dec; 36(12):1717-20. PubMed ID: 3566832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Microdialysis studies with amantadine and memantine on pharmacokinetics and effects on dopamine turnover.
    Quack G; Hesselink M; Danysz W; Spanagel R
    J Neural Transm Suppl; 1995; 46():97-105. PubMed ID: 8821045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Amantadine and memantine are NMDA receptor antagonists with neuroprotective properties.
    Kornhuber J; Weller M; Schoppmeyer K; Riederer P
    J Neural Transm Suppl; 1994; 43():91-104. PubMed ID: 7884411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of memantine on various neurobiological processes.
    Osborne NN; Beale R; Golombiowska-Nikitin K; Sontag KH
    Arzneimittelforschung; 1982; 32(10):1246-55. PubMed ID: 6185123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. On the mechanism of antidepressant-like action of berberine chloride.
    Kulkarni SK; Dhir A
    Eur J Pharmacol; 2008 Jul; 589(1-3):163-72. PubMed ID: 18585703
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Changes in cerebral neurotransmitters and metabolites induced by acute donepezil and memantine administrations: a microdialysis study.
    Shearman E; Rossi S; Szasz B; Juranyi Z; Fallon S; Pomara N; Sershen H; Lajtha A
    Brain Res Bull; 2006 Mar; 69(2):204-13. PubMed ID: 16533671
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro electrophysiological evidence predicting anticonvulsant efficacy of memantine and flunarizine.
    McLean MJ
    Pol J Pharmacol Pharm; 1987; 39(5):513-25. PubMed ID: 3333611
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential antidepressive properties of amantadine, memantine and bifemelane.
    Moryl E; Danysz W; Quack G
    Pharmacol Toxicol; 1993 Jun; 72(6):394-7. PubMed ID: 8361950
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Memantine inhibits ATP-dependent K+ conductances in dopamine neurons of the rat substantia nigra pars compacta.
    Giustizieri M; Cucchiaroni ML; Guatteo E; Bernardi G; Mercuri NB; Berretta N
    J Pharmacol Exp Ther; 2007 Aug; 322(2):721-9. PubMed ID: 17496164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nitrous oxide and xenon prevent amphetamine-induced carrier-mediated dopamine release in a memantine-like fashion and protect against behavioral sensitization.
    David HN; Ansseau M; Lemaire M; Abraini JH
    Biol Psychiatry; 2006 Jul; 60(1):49-57. PubMed ID: 16427030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The action of 1-aminoadamantane. Comparative studies with isolated nerve endings and thrombocytes on the release of serotonin and dopamine].
    Haacke U; Sturm G; Süwer V; Wesemann W; Wildenhahn G
    Arzneimittelforschung; 1977 Jul; 27(7):1481-3. PubMed ID: 578478
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo studies on the effects of memantine on dopamine metabolism in the striatum and n. accumbens of the rat.
    Clement HW; Grote C; Svensson L; Engel J; Zöfel P; Wesemann W
    J Neural Transm Suppl; 1995; 46():107-15. PubMed ID: 8821046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mechanism of action of amantadine in Parkinsonism: a review.
    Bailey EV; Stone TW
    Arch Int Pharmacodyn Ther; 1975 Aug; 216(2):246-62. PubMed ID: 1180616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Memantine prevents progressive functional neurodegeneration in rats.
    Heim C; Sontag KH
    J Neural Transm Suppl; 1995; 46():117-30. PubMed ID: 8821047
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of dimethylaminoadamantane on neuronal membranes.
    Grossmann A; Grossmann W; Jurna I
    Eur J Pharmacol; 1976 Feb; 35(2):379-88. PubMed ID: 1248512
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distribution of memantine in brain, liver, and blood of the rat.
    Wesemann W; Schollmeyer JD; Sturm G
    Arzneimittelforschung; 1982; 32(10):1243-5. PubMed ID: 6891224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.